Cognex (CGNX) to Release Earnings on Wednesday

Cognex (NASDAQ:CGNX) is anticipated to post its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect Cognex to post earnings of $0.27 per share and revenue of $261.8610 million for the quarter. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS.Parties can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Thursday, October 30, 2025 at 8:30 AM ET.

Cognex (NASDAQ:CGNX) last released its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The business had revenue of $249.09 million during the quarter, compared to the consensus estimate of $246.70 million. During the same quarter in the prior year, the firm posted $0.23 EPS. The company’s revenue for the quarter was up 4.2% compared to the same quarter last year. On average, analysts expect Cognex to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Cognex Trading Up 2.0%

Shares of Cognex stock opened at $48.27 on Wednesday. The business has a 50-day moving average price of $44.88 and a two-hundred day moving average price of $35.76. Cognex has a 1-year low of $22.67 and a 1-year high of $49.76. The company has a market cap of $8.10 billion, a P/E ratio of 67.99 and a beta of 1.50.

Cognex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were issued a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Thursday, August 14th. Cognex’s dividend payout ratio is presently 45.07%.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Cognex in a research note on Wednesday, October 8th. Citigroup reiterated a “neutral” rating and set a $37.00 price objective (up from $30.00) on shares of Cognex in a report on Monday, July 14th. Truist Financial set a $45.00 target price on shares of Cognex and gave the stock a “hold” rating in a research report on Wednesday, October 8th. Needham & Company LLC raised their price target on shares of Cognex from $36.00 to $45.00 and gave the company a “buy” rating in a research report on Thursday, July 31st. Finally, Barclays set a $55.00 price target on Cognex and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $44.93.

Insider Transactions at Cognex

In other Cognex news, EVP Sheila Marie Dipalma sold 2,000 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $45.03, for a total transaction of $90,060.00. Following the sale, the executive vice president owned 6,582 shares in the company, valued at $296,387.46. This represents a 23.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.60% of the stock is owned by insiders.

Institutional Trading of Cognex

Hedge funds and other institutional investors have recently bought and sold shares of the company. Snowden Capital Advisors LLC raised its holdings in shares of Cognex by 2.0% in the 2nd quarter. Snowden Capital Advisors LLC now owns 17,326 shares of the scientific and technical instruments company’s stock valued at $550,000 after acquiring an additional 338 shares in the last quarter. Advisory Services Network LLC bought a new position in shares of Cognex in the second quarter worth approximately $524,000. Vident Advisory LLC raised its stake in Cognex by 22.5% in the second quarter. Vident Advisory LLC now owns 15,692 shares of the scientific and technical instruments company’s stock valued at $498,000 after purchasing an additional 2,884 shares in the last quarter. Oxford Asset Management LLP bought a new stake in Cognex during the second quarter valued at approximately $426,000. Finally, Cetera Investment Advisers grew its stake in Cognex by 7.5% in the 2nd quarter. Cetera Investment Advisers now owns 13,208 shares of the scientific and technical instruments company’s stock worth $419,000 after buying an additional 920 shares in the last quarter. Institutional investors own 88.12% of the company’s stock.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.